96 related articles for article (PubMed ID: 10506427)
1. Differential permeation of propranolol enantiomers across human skin in vitro from formulations containing an enantioselective excipient.
Suedee R; Brain KR; Heard CM
Chirality; 1999; 11(9):680-3. PubMed ID: 10506427
[TBL] [Abstract][Full Text] [Related]
2. Does stereochemistry influence transdermal permeation of flurbiprofen through the rat skin?
Valentová J; Bauerová K; Farah L; Devínsky F
Arch Dermatol Res; 2010 Oct; 302(8):635-8. PubMed ID: 20582424
[TBL] [Abstract][Full Text] [Related]
3. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
4. Effect of chiral enhancers on the permeability of optically active and racemic metoprolol across hairless mouse skin.
Kommuru TR; Khan MA; Reddy IK
Chirality; 1999; 11(7):536-40. PubMed ID: 10423279
[TBL] [Abstract][Full Text] [Related]
5. Enhancement effects of (R) and (S) enantiomers and the racemate of a model enhancer on permeation of theophylline through human skin.
Vávrová K; Hrabálek A; Dolezal P
Arch Dermatol Res; 2002 Nov; 294(8):383-5. PubMed ID: 12420109
[TBL] [Abstract][Full Text] [Related]
6. S-propranolol imprinted polymer nanoparticle-on-microsphere composite porous cellulose membrane for the enantioselectively controlled delivery of racemic propranolol.
Jantarat C; Tangthong N; Songkro S; Martin GP; Suedee R
Int J Pharm; 2008 Feb; 349(1-2):212-25. PubMed ID: 17766067
[TBL] [Abstract][Full Text] [Related]
7. Effect of menthol on permeability of an optically active and racemic propranolol across guinea pig skin.
Zahir A; Kunta JR; Khan MA; Reddy IK
Drug Dev Ind Pharm; 1998 Sep; 24(9):875-8. PubMed ID: 9876540
[TBL] [Abstract][Full Text] [Related]
8. Formulation study of a patch containing propranolol by design of experiments.
Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective skin permeation of ibuprofen enantiomers: mechanistic insights from ATR-FTIR and CLSM studies based on synthetic enantiomers as naphthalimide fluorescent probes.
Che QE; Quan P; Mu M; Zhang X; Zhao H; Zhang Y; You S; Xiao Y; Fang L
Expert Opin Drug Deliv; 2014 Oct; 11(10):1513-23. PubMed ID: 24950143
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous absorption of coumarin, griseofulvin and propranolol across human scalp and abdominal skin.
Ritschel WA; Sabouni A; Hussain AS
Methods Find Exp Clin Pharmacol; 1989 Oct; 11(10):643-6. PubMed ID: 2586198
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective dissolution of propranolol hydrochloride from hydroxypropyl methylcellulose matrices.
Duddu SP; Vakilynejad M; Jamali F; Grant DJ
Pharm Res; 1993 Nov; 10(11):1648-53. PubMed ID: 8290480
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for enantiomer binding and separation of a common beta-blocker: crystal structure of cellobiohydrolase Cel7A with bound (S)-propranolol at 1.9 A resolution.
Ståhlberg J; Henriksson H; Divne C; Isaksson R; Pettersson G; Johansson G; Jones TA
J Mol Biol; 2001 Jan; 305(1):79-93. PubMed ID: 11114249
[TBL] [Abstract][Full Text] [Related]
13. Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments.
Henning A; Neumann D; Kostka KH; Lehr CM; Schaefer UF
Skin Pharmacol Physiol; 2008; 21(2):81-8. PubMed ID: 18187967
[TBL] [Abstract][Full Text] [Related]
14. Effect of penetration enhancers on in vitro percutaneous penetration of nimesulide through rat skin.
Güngör S; Bergişadi N
Pharmazie; 2004 Jan; 59(1):39-41. PubMed ID: 14964420
[TBL] [Abstract][Full Text] [Related]
15. An investigation into the influence of counterion on the RS-propranolol and S-propranolol skin permeability.
Cilurzo F; Minghetti P; Alberti E; Gennari CG; Pallavicini M; Valoti E; Montanari L
J Pharm Sci; 2010 Mar; 99(3):1217-24. PubMed ID: 19653283
[TBL] [Abstract][Full Text] [Related]
16. Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug.
Ahmed S; Imai T; Otagiri M
Enantiomer; 1997; 2(3-4):181-91. PubMed ID: 9676267
[TBL] [Abstract][Full Text] [Related]
17. Composite membrane of bacterially-derived cellulose and molecularly imprinted polymer for use as a transdermal enantioselective controlled-release system of racemic propranolol.
Bodhibukkana C; Srichana T; Kaewnopparat S; Tangthong N; Bouking P; Martin GP; Suedee R
J Control Release; 2006 Jun; 113(1):43-56. PubMed ID: 16713005
[TBL] [Abstract][Full Text] [Related]
18. Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat.
Bode W; Toet AE; Stolker AA; van Ginkel LA; Groen K; Wemer J; de Wildt DJ
Chirality; 1995; 7(8):626-31. PubMed ID: 8593256
[TBL] [Abstract][Full Text] [Related]
19. Skin permeation enhancement potential of Aloe Vera and a proposed mechanism of action based upon size exclusion and pull effect.
Cole L; Heard C
Int J Pharm; 2007 Mar; 333(1-2):10-6. PubMed ID: 17088033
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs.
Udata C; Tirucherai G; Mitra AK
J Pharm Sci; 1999 May; 88(5):544-50. PubMed ID: 10229647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
